For this year's post-ASCO Lung Cancer panel discussion, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center, and Founder and...
2025 동아시아 폐암 이미지 라이브러리의 일환으로 서정민 박사(분당서울대학교병원)가 절제 가능한 비소세포 폐암의 수술 주변 관리에 대해 논의합니다. 2025 동아시아 폐암 영상 라이브러리의 일환으로, 김진용 박사(삼성메디컬센터)는 EGFR 돌연변이가 있는 비소세포...
For the 2025 Case Based Panel Discussions, a panel of oncologists consisting of Dr. Isabel Preeshagul, Dr. Deborah Doroshow and Dr. Christine Garcia...
The 2025 Targeted Therapies in Lung Cancer Patient Forum was a live, virtual, interactive patient education event presented in March 2025 and led by...
The panel discusses the current standard of care for patients with head and neck cancer who need surgery, the findings of the Keynote 689 study, which...
Las biopsias líquidas están revolucionando la forma en que combatimos el cáncer, ofreciendo un futuro donde la detección y el tratamiento son más rápidos, precisos y menos invasivos.
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.